Lv13
10 积分 2025-06-27 加入
N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression
4小时前
待确认
N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression
1天前
求助中
Development and clinical application of bispecific antibody in the treatment of colorectal cancer
1个月前
已完结
Neoadjuvant cadonilimab plus FLOT chemotherapy in locally advanced gastric/gastroesophageal junction adenocarcinoma: A multicenter, phase 2 study
1个月前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
1个月前
已完结
HERIZON-GEA-01: Zanidatamab + chemo ± tislelizumab for 1L treatment of HER2-positive gastroesophageal adenocarcinoma
1个月前
已完结
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
1个月前
已完结
The present and future of bispecific antibodies for cancer therapy
1个月前
已完结
Is Weight Loss During Chemotherapy for Pancreatic Cancer Prognostic?
2个月前
已完结
Addition of Algenpantucel-L Immunotherapy to Standard Adjuvant Therapy for Pancreatic Cancer: a Phase 2 Study
2个月前
已完结
皖公网安备34019202002308
